The InsidesTM Company is a leading provider of therapeutic Chyme Reinfusion solutions for the management of High-Output Enteroatmospheric Fistulas and High-Output Enterostomies.
The Insides Company
The Insides Company was established in 2017, building on research conducted at the University of Auckland Medical School. Initially focusing only on The InsidesTM Systemfi, the company has since broadened its scope, expanding its technologies to service the emerging market of chyme refeeding.
The Insides Company develops life-changing medical devices for people with chronic and acute intestinal conditions including inflammatory bowel disease and colorectal cancer. Our mission is to empower patients to take control of their condition.
We work with hospitals globally and are always interested in working with forward-thinking doctors looking to push the boundaries of colorectal care. If you are interested in partnering for a clinical trial or hearing from us when we are commercially ready, please reach out to us.